TARDBP and amyotrophic lateral sclerosis: Indeed, phosphorylation of TDP-43 at the Ser409/410 site is a hallmark of clinical ALS pathology in impacted nervous system tissues, as well as in preclinical ALS models (including the Prp-TDP43A315T mouse model, as reported above in Figure 3C) (4).